耐多药结核的诊疗与预防
被引量:1
Diagnosis,treatment and prevention of multidrug-resistant tuberculosis
摘要
耐多药结核(multidrug—resistant tuberculosis,MDR—TB)是指结核分枝杆菌对至少2种一线抗结核药物耐药,其中至少包括同时对异烟肼和利福平耐药。MDR—TB具有治疗费用高、治愈率低、死亡率高的特点,其发生率的增高以及广泛传播对结核病治疗及控制带来严峻挑战和威胁,
出处
《中国感染控制杂志》
CAS
2009年第6期375-379,共5页
Chinese Journal of Infection Control
参考文献12
-
1WHO/IUATLD. Anti-tuberculosis drug resistance in the world: The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance [R]. Geneva: WHO, 1997.
-
2WHO/IUATLD. Anti tuberculosis drug resistance in the world: The WHO/IUATI.D global project on anti-tubercu losis drug resistances surveillance. Report NO. 2 [R]. Geneva: WHO, 2000.
-
3WHO/IUATI.D. Anti-tuberculosis drug resistance in the world: The WHO/IUATLD global project on anti tuberculosis drug resistances surveillance. Report NO. 3 [R]. Gene va: WHO, 2004.
-
4Blower S M, Chou T. Modeling the emergence of the "hot zones": tuberculosis and the amplification dynamics of drug resistance[J]. Nature Medicine, 2004, 10 (10): 1111-1116.
-
5Chukanov V I, Kuz'mina N V. The immunity status of pulmonary tuberculosis patients excreting drug-resistant Mycobacte rium tuberculosis[J]. Probl Tuberk, 1996 (1): 17 - 19.
-
6Cockerill F R,Williams D E,Eisenach K D,et al. Prospective evaluation of the utility of molecular techniques for diagnosing nosocomial transmission of multidrug resistant tuberculosis [J]. Mayo Clin Proc, 1996,71 (3):221 - 229.
-
7Bifani P J, Plikaytis BB, Kapur V, et al. Origin and interstate spread of a New York City multidrug-resistanee Mycobacterium tuberculosis clone family [J]. JAMA, 1996,275 (6) : 452 - 457.
-
8Bastan I, Calebunders R. Treatment and prevention of multidrug resistant tuberculosis[J]. Drugs, 1999,58:633 - 661.
-
9Reichman, L B. Multidrug resistance in the World: The present situation[J]. Chemotherapy, 1996,42(Suppl. 3) :2 - 9.
-
10朱莉贞.耐药、耐多药肿结核的治疗及药物选择[G].中华医学会结核病学会2002学术会议论文汇编,2002:14-18.
同被引文献19
-
1World Health Organization. Anti-tuberculosis drug resistance in the world fourth global report [ R ]. Geneva: World Health Organiza- tion ,2008, ( WHO/HTM/TB/2008.394 ).
-
2Abdelaal A ,E1-Ghaffar HA ,Zaghloul MH, et al. Genotypic detec- tion of rifampicin and isoniazid resistant Mycobacterium tubercu- losis strains by DNA seqencing:a randomized trial [ J ]. Ann Clin Microbiol Antimicrob, 2009,8 ( 4 ) : 243-248.
-
3World Health Organization. Guidelines for theprogrammatic man- agement of drug-resistant tuberculosis: emergency update 2008 [ C ]. Geneva: World Health Organization,2008.
-
4Conde MB, Efron A, Loredo C, et al. Moxifloxacin Versus etham- butol in the initial treatment of tuberculosis:a double-blind, ran- domized, Controlled phase Ⅱ trial [ J ]. Lancet, 2009, 373 (9670) : 1183-1189.
-
5Caminero JA, Sotgiu C, Zunila A, et al. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis [ J ]. Laneel Infect Dis ,2010,10 (9) :621-629.
-
6Hugonnet JE, Tremblay LW, Boshoff H, et al. Meropenem-clavu- lanate is effective against extensively drugresistant Mycobaeterium tuberculosis [ J ]. Science,2009,323 (5918) : 1215-1218.
-
7Mitnidk CD, Shin SS, Seung KJ, et al. Comprehensive treatment ofextensively drug-resistant tuberculosis [ J ]. N Engl J Med, 2008, 359(6) :563-574.
-
8Berry M, Kon OM. Muhidrug and extensively drug-resistant tuber- culosis: an emerging threat [ J ]. Eur Respir Rev,2009,18 ( 114 ) : 195-197.
-
9侯海龙,许礼发.中药在耐多药结核分支杆菌感染中的应用前景[J].医学动物防制,2007,23(11):825-827. 被引量:6
-
10黄洁,尉理梁.百合固金汤治疗耐多药结核病33例观察[J].浙江中医杂志,2009,44(6):427-427. 被引量:16
二级引证文献5
-
1韩珍,李晓芬,冷雪.复治肺结核患者耐多药的影响因素分析[J].国际检验医学杂志,2015,36(11):1568-1570. 被引量:4
-
2丁密,盛锡霞.影响结核病患者耐药的因素及护理对策[J].中国实用医刊,2015,42(21):15-16. 被引量:1
-
3李悦琳,汪洋,刘勇,叶庆,王玥莲.中西医结合治疗耐多药肺结核病临床研究[J].亚太传统医药,2016,12(16):107-108. 被引量:9
-
4古丽巴哈尔·阿不拉合买提,夏衣扎提·库尔曼.中西医结合治疗耐多药肺结核50例疗效观察[J].中国社区医师,2017,33(7):99-100. 被引量:5
-
5冯秀莉,曹延伦,任欣欣,崔丹,王建梅,李毅.益气润肺汤联合黄芪注射液对耐药肺结核患者临床症状及机体免疫功能影响[J].世界中西医结合杂志,2019,14(10):1423-1426. 被引量:21
-
1阮汉利,张和武,胡旻慧.耐多药结核病的治疗[J].内科急危重症杂志,2002,8(4):210-212. 被引量:2
-
2邹级谦.复治肺结核标准化疗方案之我见[J].中华结核和呼吸杂志,2009,32(8):564-565. 被引量:5
-
3谭守勇,伍小英.耐多药结核病的防治[J].广东医学,2010,31(15):1913-1915. 被引量:7
-
4曹咏红,曹子中,李勇.耐多药结核病诊断与治疗新进展[J].中国医师进修杂志,2010,33(12):70-71. 被引量:5
-
5杨松,张耀亭.耐药结核病的综合治疗研究进展[J].临床肺科杂志,2010,15(2):220-221. 被引量:14
-
6梁立波,李玲,孙宏,刘颖,吴群红.耐多药结核流行及影响因素研究进展[J].中国公共卫生,2014,30(9):1221-1225. 被引量:22
-
7李强,卢洪洲.耐多药结核及泛耐药结核诊治的新认识[J].诊断学理论与实践,2015,14(1):13-16. 被引量:10
-
8林娅君.影响耐多药肺结核患者生活质量的相关因素分析[J].结核病健康教育,2008(2):62-65. 被引量:2
-
9徐丽玲,赵根明.耐多药结核病的特点及其控制[J].现代预防医学,2005,32(8):914-915. 被引量:5
-
10赵恒敏,王卫华.抗耐多药结核病新药的研究进展[J].中国防痨杂志,2012,34(5):324-326. 被引量:6